Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters

Infection and Immunity
Yuanguo WangXingmin Sun

Abstract

The symptoms of Clostridium difficile infection (CDI) are attributed largely to two C. difficile toxins, TcdA and TcdB. Significant efforts have been devoted to developing vaccines targeting both toxins through parenteral immunization routes. However, C. difficile is an enteric pathogen, and mucosal/oral immunization would be particularly useful to protect the host against CDI, considering that the gut is the main site of disease onset and progression. Moreover, vaccines directed only against toxins do not target the cells and spores that transmit the disease. Previously, we constructed a chimeric vaccine candidate, mTcd138, comprised of the glucosyltransferase and cysteine proteinase domains of TcdB and the receptor binding domain of TcdA. In this study, to develop an oral vaccine that can target both C. difficile toxins and colonization/adhesion factors, we expressed mTcd138 in a nontoxigenic C. difficile (NTCD) strain, resulting in strain NTCD_mTcd138. Oral immunization with spores of NTCD_mTcd138 provided mice full protection against infection with a hypervirulent C. difficile strain, UK6 (ribotype 027). The protective strength and efficacy of NTCD_mTcd138 were further evaluated in the acute CDI hamster model. Oral immuniza...Continue Reading

References

Jun 2, 2000·Journal of Clinical Microbiology·F BarbutJ C Petit
Mar 11, 2005·Journal of Leukocyte Biology·Diego AlignaniMaría C Pistoresi-Palencia
Jun 7, 2005·Postgraduate Medical Journal·I Tonna, P D Welsby
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fred A ZarMelinda B Davis
Feb 22, 2008·Journal of Clinical Microbiology·Thomas AkerlundLars G Burman
Apr 9, 2008·Trends in Microbiology·Thomas Jank, Klaus Aktories
Oct 14, 2008·Gastroenterology·Xinhua ChenCiarán P Kelly
Mar 25, 2009·Infection and Immunity·Xiangyun HeHanping Feng
Jun 5, 2010·Expert Opinion on Investigational Drugs·Hoonmo L KooHerbert L Dupont
Sep 25, 2010·Research in Microbiology·David A BurnsNigel P Minton
Nov 26, 2010·Current Opinion in Gastroenterology·Caoilfhionn O'Donoghue, Lorraine Kyne
Mar 8, 2011·Analytical and Bioanalytical Chemistry·Leslie D KnechtSylvia Daunert
Mar 15, 2011·Current Protocols in Microbiology·Laurent BouillautJoseph A Sorg
Mar 19, 2011·Journal of Medical Microbiology·Ciarán P Kelly, Lorraine Kyne
Jun 11, 2011·The Journal of Biological Chemistry·Robert P Fagan, Neil F Fairweather
Oct 18, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ethan GoughAmee R Manges
May 4, 2012·Expert Review of Vaccines·Fabien Rebeaud, Martin F Bachmann
Aug 2, 2012·Antimicrobial Agents and Chemotherapy·Stephen A VillanoDale N Gerding
Aug 25, 2012·Frontiers in Cellular and Infection Microbiology·Rory N Pruitt, D Borden Lacy
Feb 23, 2013·International Journal of Pharmaceutics·Jwala RenukuntlaAshim K Mitra
Apr 4, 2013·The Lancet Infectious Diseases·Kathryn Senior
May 1, 2013·Microbiology·Robert G K DonaldAnnaliesa S Anderson
Oct 31, 2014·Journal of Medical Microbiology·Zhenwen ZhouZhigang Liu
Feb 11, 2015·Human Vaccines & Immunotherapeutics·Song ZhaoXingmin Sun
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Feb 11, 2016·Nature Reviews. Gastroenterology & Hepatology·Larry K Kociolek, Dale N Gerding
Apr 26, 2017·Advanced Drug Delivery Reviews·Julia E Vela RamirezNicholas A Peppas
May 8, 2018·International Journal of Pharmaceutics·Md Jasim Uddin, Harvinder Singh Gill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.